Clinical Trials

Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

300 enrolled

Breast Neoplasms

NCT05394259 2026-04-15

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Phase 1 Recruiting

36 enrolled

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT07076485 2026-04-15

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Phase 2 Recruiting

768 enrolled

Breast Neoplasms

NCT07198581 2026-04-15

ALLIANCE

174 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07504770 2026-04-15

Surgical Glove

84 enrolled

Breast Neoplasms

NCT07531836 2026-04-15

PREHAB-BC65

90 enrolled

Frailty, Breast Neoplasms, Sarcopenia

NCT07532096 2026-04-15

Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer

240 enrolled

Breast Neoplasms

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

2,000 enrolled

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

29 enrolled

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

39 enrolled

Breast Neoplasms

NCT02311959 2026-04-14

MAPAM-01

Phase 3 Completed

450 enrolled

Phase 2 Active not recruiting

Breast Neoplasms, Carcinoma in Situ

NCT04920708 2026-04-14

FAIM

57 enrolled

Breast Neoplasms

NCT05609435 2026-04-14

Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

Phase NA Completed

104 enrolled

Breast Neoplasms

NCT07225309 2026-04-14

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

BreastGastrointestinalGenitourinaryHead & Neck

300 enrolled

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07400523 2026-04-14

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

446 enrolled

Breast Neoplasms

NCT07527468 2026-04-14

HISMAR

228 enrolled

Margins of Excision, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

NCT07527689 2026-04-14

HARVEST-PRO

1,950 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07527806 2026-04-14

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

156 enrolled

Breast Neoplasms

NCT07528638 2026-04-14

Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)

6 enrolled

Phase 3 Not yet recruiting

Breast Neoplasms

NCT07528716 2026-04-14

Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted Therapy

280 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms

NCT07528898 2026-04-14

Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.

100 enrolled

Breast Neoplasms

NCT07529353 2026-04-14

EXCAP-hEAT

20 enrolled

Phase 2 Active not recruiting

Breast Neoplasms

NCT03650894 2026-04-13

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

30 enrolled

Breast Neoplasms

NCT04342546 2026-04-13

PRETORIA

250 enrolled

Phase NA Active not recruiting

Breast Neoplasms

NCT04522648 2026-04-13

PROTECT

250 enrolled

Breast Neoplasms, Lymphedema

NCT04768426 2026-04-13

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

Phase 2 Recruiting

40 enrolled

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04895761 2026-04-13

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

6 enrolled

Breast Neoplasms

NCT05095207 2026-04-13

Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Phase 1/2 Recruiting

42 enrolled

Phase NA Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT05215769 2026-04-13

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

243 enrolled 11 charts

BreastThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT05313191 2026-04-13

ReRT